In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004
about
Telithromycin is active against Mycobacterium avium in mice despite lacking significant activity in standard in vitro and macrophage assays and is associated with low frequency of resistance during treatmentThe ketolide antibiotics HMR 3647 and HMR 3004 are active against Toxoplasma gondii in vitro and in murine models of infectionSusceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agentsIn vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine)In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany.In vitro susceptibilities of aerobic and facultative non-spore-forming gram-positive bacilli to HMR 3647 (RU 66647) and 14 other antimicrobials.Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolIn vitro activities of the ketolide HMR 3647 against recent gram-positive clinical isolates and Haemophilus influenzae.Activity of HMR 3647 compared to those of five agents against Haemophilus influenzae and moraxella catarrhalis by MIC determination and time-kill assayIn vitro activity of the new ketolide HMR3647 in comparison with those of macrolides and pristinamycins against Enterococcus spp.Vancomycin-resistant enterococci.Ketolide treatment of Haemophilus influenzae experimental pneumoniaIn vitro activities of two ketolides, HMR 3647 and HMR 3004, against gram-positive bacteriaIn vitro activities of ketolides HMR 3647 [correction of HRM 3647] and HMR 3004 [correction of HRM 3004], levofloxacin, and other quinolones and macrolides against Neisseria spp. and Moraxella catarrhalis.Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobes.Susceptibilities to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 Pneumococci from 10 central and Eastern European countriesComparative antianaerobic activities of the ketolides HMR 3647 (RU 66647) and HMR 3004 (RU 64004)Antibacterial activity of RU 64004 (HMR 3004), a novel ketolide derivative active against respiratory pathogensIn vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae.In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia.Kinetic study of the inflammatory response in Streptococcus pneumoniae experimental pneumonia treated with the ketolide HMR 3004.Immunomodulating effects of HMR 3004 on pulmonary inflammation caused by heat-killed Streptococcus pneumoniae in mice.
P2860
Q28343803-16A20504-B5F7-4FF9-81B5-ECEFD4325973Q28379168-8D64EF02-3D5C-45AD-9018-075CDDBC3C4DQ33691239-2FF6C90E-2A9A-44EF-91A6-72F382C65F34Q33693025-D5DE6076-763F-4B79-A91A-A665AD4B559CQ33693715-EDE24D03-5598-4B52-AEEA-5D00E3E9CAA6Q33695123-174C682C-C942-4C91-B3B3-58A90903A57EQ33695332-855C37D4-44E4-44EC-9E82-6D1A6A5A407AQ33698624-A7373C0F-57BC-4531-A9B1-3C62075CAD31Q33702256-5B77B569-B16A-4815-B097-EDC1DBBB4894Q33703872-EC04FB2C-CBE2-45ED-A50B-FF0CB1E36EEAQ33975592-43A6CC5E-F3D6-40DA-8419-9672C0417013Q33976544-464D347B-C3AF-4BE5-8096-E7E0EE6CC0D6Q33976715-FF0035B9-6EC0-4D01-85A5-8066F3B6F1F0Q33976786-09FC2331-21BE-4748-9418-8054BB7B57E0Q33978155-55D67CE5-E1B7-4DD1-9B47-2A9BD970AD21Q34105521-CDC0305E-CF69-4D8D-9DBB-CCB6BD14E6B9Q35138238-4F8B37D1-75E6-41D4-93E4-63210DF32C63Q35138464-35ABBB30-9419-4F1A-B2D8-410C4CE2595DQ37880865-89AB594A-B88B-45C3-AB6D-DB722EB639DCQ39469546-6082ECEB-25CD-4405-8C26-4573D077595FQ39476004-4D993FD2-A15D-4D35-BC48-678D8F4B723FQ39559747-EA40027F-D0AF-46D0-B6E0-FCCED49319BE
P2860
In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004
description
1997 nî lūn-bûn
@nan
1997 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004
@ast
In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004
@en
type
label
In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004
@ast
In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004
@en
prefLabel
In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004
@ast
In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004
@en
P2093
P2860
P356
P1476
In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004
@en
P2093
Biedenbach DJ
P2860
P304
P356
10.1128/AAC.41.2.454
P407
P577
1997-02-01T00:00:00Z